BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bell D, Hanna EY, Weber RS, DeMonte F, Triantafyllou A, Lewis JS Jr, Cardesa A, Slootweg PJ, Stenman G, Gnepp DR, Devaney KO, Rodrigo JP, Rinaldo A, Wenig BM, Westra WH, Bishop JA, Hellquist H, Hunt JL, Kusafuka K, Perez-Ordoñez B, Williams MD, Takes RP, Ferlito A. Neuroendocrine neoplasms of the sinonasal region. Head Neck 2016;38 Suppl 1:E2259-66. [PMID: 26041714 DOI: 10.1002/hed.24152] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 López F, Grau JJ, Medina JA, Alobid I. Consenso español para el tratamiento de los tumores nasosinusales. Acta Otorrinolaringológica Española 2017;68:226-34. [DOI: 10.1016/j.otorri.2016.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Libera L, Ottini G, Sahnane N, Pettenon F, Turri-Zanoni M, Lambertoni A, Chiaravalli AM, Leone F, Battaglia P, Castelnuovo P, Uccella S, Furlan D, Facco C, Sessa F. Methylation Drivers and Prognostic Implications in Sinonasal Poorly Differentiated Carcinomas. Cancers (Basel) 2021;13:5030. [PMID: 34638515 DOI: 10.3390/cancers13195030] [Reference Citation Analysis]
3 Hachem RA, Beer-furlan A, Elkhatib A, Rangarajan S, Prevedello D, Blakaj D, Bhatt A, Carrau R. Modern Treatment Outcomes in Sinonasal Malignancies. Curr Otorhinolaryngol Rep 2016;4:266-75. [DOI: 10.1007/s40136-016-0133-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Sipos B. [Neuroendocrine neoplasms of the auditory, olfactory, and visual sensory organs]. Pathologe 2018;39:255-63. [PMID: 29392404 DOI: 10.1007/s00292-017-0411-9] [Reference Citation Analysis]
5 Jensen K, Sharma MB, Lenler-Eriksen S, Friis P, Holm AIS. Simultaneous integrated prophylactic cranial irradiation in sino-nasal cancer. Clin Transl Radiat Oncol 2017;2:59-62. [PMID: 29658002 DOI: 10.1016/j.ctro.2017.01.007] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Mehta GU, Raza SM, Su SY, Hanna EY, DeMonte F. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase. J Neurooncol 2020;150:367-75. [PMID: 32424573 DOI: 10.1007/s11060-020-03537-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Keilin CA, Vankoevering KK, Mchugh JB, Mckean EL. Sinonasal Neuroendocrine Carcinoma: 15 Years of Experience at a Single Institution. J Neurol Surg B Skull Base. [DOI: 10.1055/s-0041-1740968] [Reference Citation Analysis]
8 Dogan S, Vasudevaraja V, Xu B, Serrano J, Ptashkin RN, Jung HJ, Chiang S, Jungbluth AA, Cohen MA, Ganly I, Berger MF, Momeni Boroujeni A, Ghossein RA, Ladanyi M, Chute DJ, Snuderl M. DNA methylation-based classification of sinonasal undifferentiated carcinoma. Mod Pathol 2019;32:1447-59. [PMID: 31186531 DOI: 10.1038/s41379-019-0285-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
9 Schneider JR, Shatzkes DR, Scharf SC, Tham TM, Kulason KO, Buteau FA, Del Prete M, Chakraborty S, Anderson TA, Asiry S, Beauregard JM, Langer DJ, Costantino PD, Boockvar JA. Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory Esthesioneuroblastoma. Oper Neurosurg (Hagerstown) 2018;15:100-9. [PMID: 29554305 DOI: 10.1093/ons/opy028] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
10 Bell D. Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma. Head Neck Pathol 2018;12:22-30. [PMID: 29427030 DOI: 10.1007/s12105-018-0887-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 Campos HG, Altemani AM, Altemani J, Soares DF, Reis F. Poorly differentiated large-cell neuroendocrine carcinoma of the paranasal sinus. Radiol Bras 2018;51:269. [PMID: 30202133 DOI: 10.1590/0100-3984.2016.0184] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Classe M, Burgess A, El Zein S, Wassef M, Herman P, Mortuaire G, Leroy X, Malouf GG, Verillaud B. Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma. Histopathology 2019;75:853-64. [PMID: 31306501 DOI: 10.1111/his.13954] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 López F, Grau JJ, Medina JA, Alobid I. Spanish Consensus for the Management of Sinonasal Tumors. Acta Otorrinolaringologica (English Edition) 2017;68:226-34. [DOI: 10.1016/j.otoeng.2017.06.008] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Takahashi Y, Gleber‐netto FO, Bell D, Roberts D, Xie T, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma. Head & Neck 2019. [DOI: 10.1002/hed.25748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 López F, Lund VJ, Suárez C, Snyderman CH, Saba NF, Robbins KT, Vander Poorten V, Strojan P, Mendenhall WM, Rinaldo A, Ferlito A. The Impact of Histologic Phenotype in the Treatment of Sinonasal Cancer. Adv Ther 2017;34:2181-98. [PMID: 28871554 DOI: 10.1007/s12325-017-0605-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
16 Czapiewski P, Kunc M, Haybaeck J. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment. Oncotarget 2016;7:52584-96. [PMID: 27256979 DOI: 10.18632/oncotarget.9683] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
17 Lahma J, Hejjouji R, Gicquel P, Essakalli L. Large cell neuroendocrine carcinoma of the nasal cavity: an extremely rare and new distinct entity. Pan Afr Med J 2018;30:188. [PMID: 30455817 DOI: 10.11604/pamj.2018.30.188.14992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
18 Francies O, Makalanda L, Paraskevopolous D, Adams A. Imaging review of the anterior skull base. Acta Radiol Open 2018;7:2058460118776487. [PMID: 29872547 DOI: 10.1177/2058460118776487] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Riobello C, López-Hernández A, Cabal VN, García-Marín R, Suárez-Fernández L, Sánchez-Fernández P, Vivanco B, Blanco V, López F, Franchi A, Llorente JL, Hermsen MA. IDH2 Mutation Analysis in Undifferentiated and Poorly Differentiated Sinonasal Carcinomas for Diagnosis and Clinical Management. Am J Surg Pathol 2020;44:396-405. [PMID: 31876581 DOI: 10.1097/PAS.0000000000001420] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 Desai DD, Brandon BM, Perkins EL, Ebert CS, Zanation AM, Thorp BD. Staging of Sinonasal and Ventral Skull Base Malignancies. Otolaryngol Clin North Am 2017;50:257-71. [PMID: 28314399 DOI: 10.1016/j.otc.2016.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
21 Agaimy A, Franchi A, Lund VJ, Skálová A, Bishop JA, Triantafyllou A, Andreasen S, Gnepp DR, Hellquist H, Thompson LDR, Rinaldo A, Ferlito A. Sinonasal Undifferentiated Carcinoma (SNUC): From an Entity to Morphologic Pattern and Back Again-A Historical Perspective. Adv Anat Pathol 2020;27:51-60. [PMID: 31876536 DOI: 10.1097/PAP.0000000000000258] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
22 Rooper LM, Bishop JA, Faquin WC, Foss RD, Gallia GL, Jo VY, Lewis JS Jr, Nishino M, Stelow EB, Thompson LDR, Wenig BM, Westra WH. Sinonasal Tumors With Neuroepithelial Differentiation (Olfactory Carcinoma): Delineation of Their Pathologic and Clinical Features With Insights into Their Relationship to Olfactory Neuroblastoma and Sinonasal Carcinoma. Am J Surg Pathol 2022. [PMID: 35420559 DOI: 10.1097/PAS.0000000000001908] [Reference Citation Analysis]
23 Rooper LM, Bishop JA, Westra WH. INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors. Am J Surg Pathol 2018;42:665-71. [PMID: 29438167 DOI: 10.1097/PAS.0000000000001037] [Cited by in Crossref: 45] [Cited by in F6Publishing: 21] [Article Influence: 15.0] [Reference Citation Analysis]
24 Casar-Borota O, Botling J, Granberg D, Stigare J, Wikström J, Boldt HB, Kristensen BW, Pontén F, Trouillas J. Serotonin, ATRX, and DAXX Expression in Pituitary Adenomas: Markers in the Differential Diagnosis of Neuroendocrine Tumors of the Sellar Region. Am J Surg Pathol 2017;41:1238-46. [PMID: 28719461 DOI: 10.1097/PAS.0000000000000908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
25 Bell D, Bell A, Ferrarotto R, Glisson B, Takahashi Y, Fuller G, Weber R, Hanna E. High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome. Ann Diagn Pathol 2020;49:151622. [PMID: 32927372 DOI: 10.1016/j.anndiagpath.2020.151622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Thompson LD. Small round blue cell tumors of the sinonasal tract: a differential diagnosis approach. Mod Pathol 2017;30:S1-S26. [PMID: 28060373 DOI: 10.1038/modpathol.2016.119] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
27 Kilic S, Kilic SS, Baredes S, Liu JK, Eloy JA. Survival, Morbidity, and Quality-of-Life Outcomes for Sinonasal and Ventral Skull Base Malignancies. Otolaryngologic Clinics of North America 2017;50:467-80. [DOI: 10.1016/j.otc.2016.12.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
28 Konukiewitz B, Agaimy A, Weichert W, Klöppel G. Neuroendokrine Neoplasien der Kopf-Hals-Region. Pathologe 2018;39:27-34. [DOI: 10.1007/s00292-017-0404-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
29 López-hernández A, Vivanco B, Franchi A, Bloemena E, Cabal VN, Potes S, Riobello C, García-inclán C, López F, Llorente JL, Hermsen M. Genetic profiling of poorly differentiated sinonasal tumours. Sci Rep 2018;8. [DOI: 10.1038/s41598-018-21690-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
30 Shah K, Perez-Ordóñez B. Neuroendocrine Neoplasms of the Sinonasal Tract: Neuroendocrine Carcinomas and Olfactory Neuroblastoma. Head Neck Pathol 2016;10:85-94. [PMID: 26830400 DOI: 10.1007/s12105-016-0696-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
31 Shen J, Cui H, Feng S. An isolated orbital mass with proptosis and diplopia: an uncommon metastasis from intracranial olfactory neuroblastoma in a chinese patient. Onco Targets Ther 2016;9:5281-6. [PMID: 27601919 DOI: 10.2147/ott.si09929] [Reference Citation Analysis]
32 Heiland L, Heiland K. Functional Olfactory Neuroblastoma Inducing Symptomatic SIADH. Ear Nose Throat J 2021;:1455613211022102. [PMID: 34134537 DOI: 10.1177/01455613211022102] [Reference Citation Analysis]
33 Rooper LM, Bishop JA. Sinonasal Small Round Blue Cell Tumors: An Immunohistochemical Approach. Surg Pathol Clin 2017;10:103-23. [PMID: 28153129 DOI: 10.1016/j.path.2016.10.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
34 Hermsen MA, Riobello C, García-Marín R, Cabal VN, Suárez-Fernández L, López F, Llorente JL. Translational genomics of sinonasal cancers. Semin Cancer Biol 2020;61:101-9. [PMID: 31560943 DOI: 10.1016/j.semcancer.2019.09.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
35 Issa K, Smith BD, Kaplan SJ, Madden J, Jang DW, Zomorodi A, Brizel D, Abi Hachem R. A systematic review on sinonasal mixed adenoneuroendocrine carcinoma. Int Forum Allergy Rhinol 2021. [PMID: 34013656 DOI: 10.1002/alr.22811] [Reference Citation Analysis]
36 Famuyide A, Juliano A, Moonis G. MRI of Sinonasal Malignancies. Top Magn Reson Imaging 2021;30:139-49. [PMID: 34096897 DOI: 10.1097/RMR.0000000000000288] [Reference Citation Analysis]
37 Wakely PE Jr. Diagnostic traps awaiting the head/neck pathologist: "Cytoplasm-poor" neoplasms. Ann Diagn Pathol 2019;42:78-86. [PMID: 31382078 DOI: 10.1016/j.anndiagpath.2019.07.005] [Reference Citation Analysis]
38 Schreiber A, Rampinelli V, Ferrari M, Mattavelli D, Farina D, Battocchio S, Nicolai P. Diagnostic reliability of pretreatment biopsy in malignant nasoethmoidal tumors: A retrospective study of 77 cases. Laryngoscope 2018;128:1772-7. [PMID: 29314070 DOI: 10.1002/lary.27077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]